Fairfax Financial Holdings’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Fairfax Financial Holdings’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,600	Closed	-$158K	–	66
2020 Q4	$158K	Buy	+8,600	New	+$157K	0.01%	59

Fairfax Financial Holdings's CBMG Position: Q1 2021 in Review

Fairfax Financial Holdings sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 8,600 shares — an estimated $158K sold.

Fairfax Financial Holdings first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $158K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Fairfax Financial Holdings reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Fairfax Financial Holdings sold 8,600 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $158K.
Fairfax Financial Holdings first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
Fairfax Financial Holdings's Cellular Biomedicine Group, Inc. position peaked at $158K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Fairfax Financial Holdings's 13F filing for Q1 2021, filed 14 May 2021.